- Home
- AKRO vs CC Comparison
AKRO vs CC Comparison
Compare AKRO & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CC
- Stock Information
- Founded
- AKRO 2017
- CC 2014
- Country
- AKRO United States
- CC United States
- Employees
- AKRO N/A
- CC N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CC Major Chemicals
- Sector
- AKRO Health Care
- CC Industrials
- Exchange
- AKRO Nasdaq
- CC Nasdaq
- Market Cap
- AKRO 2.8B
- CC 2.9B
- IPO Year
- AKRO 2019
- CC N/A
- Fundamental
- Price
- AKRO $37.63
- CC $11.36
- Analyst Decision
- AKRO Strong Buy
- CC Buy
- Analyst Count
- AKRO 9
- CC 9
- Target Price
- AKRO $76.29
- CC $22.00
- AVG Volume (30 Days)
- AKRO 1.3M
- CC 4.3M
- Earning Date
- AKRO 05-09-2025
- CC 05-26-2025
- Dividend Yield
- AKRO N/A
- CC 8.80%
- EPS Growth
- AKRO N/A
- CC N/A
- EPS
- AKRO N/A
- CC 0.57
- Revenue
- AKRO N/A
- CC $5,782,000,000.00
- Revenue This Year
- AKRO N/A
- CC $5.02
- Revenue Next Year
- AKRO N/A
- CC $4.12
- P/E Ratio
- AKRO N/A
- CC $19.93
- Revenue Growth
- AKRO N/A
- CC N/A
- 52 Week Low
- AKRO $17.86
- CC $9.33
- 52 Week High
- AKRO $58.40
- CC $29.21
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- CC 41.27
- Support Level
- AKRO $36.46
- CC $10.74
- Resistance Level
- AKRO $39.13
- CC $11.70
- Average True Range (ATR)
- AKRO 3.04
- CC 0.98
- MACD
- AKRO 0.06
- CC 0.06
- Stochastic Oscillator
- AKRO 57.38
- CC 45.93
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CC Chemours Company (The)
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.